Clinical Trial Detail

NCT ID NCT01759303
Title Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Vector Oncology
Indications

osteosarcoma

Therapies

Pazopanib

Age Groups: adult

No variant requirements are available.